Related Articles
Concurrent palliative external radiotherapy with sorafenib or doxorubicin for bulky differentiated thyroid carcinoma: A case report
Sorafenib in metastatic radioactive iodine‑refractory differentiated thyroid cancer: A pilot study
IGF2 is a potential factor in RAI‑refractory differentiated thyroid cancer
Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography
RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine‑refractory differentiated thyroid carcinoma